Vessel Sealing Devices Market To Hold a High Potential for Growth by 2028: Grand View Research Inc.

 Vessel Sealing Devices Market Growth & Trends

The global vessel sealing devices market size is anticipated to reach USD 2.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 8.1% from 2021 to 2028. The key factors driving the market growth include the rising number of surgeries across the globe, aging population, and technological advancements.

The COVID-19 pandemic resulted in several challenges such as logistical bottlenecks, low demand, decreased sales and marketing activities, and reduced sales. The key impact, however, was the cancellation or postponement of elective surgeries during the pandemic. Most nations went under lockdown with the implementation of movement restrictions while academic societies and regulatory bodies recommended postponement of elective surgical procedures. According to Harvard Business Review, around a 4.8% GDP decline in the American economy, in the first quarter of 2020, could be attributed to deferred healthcare services, in particular delayed elective procedures. The resumption of elective surgeries is expected to lead to increased demand over the coming years.

The number of surgeries performed is a key contributor to the market growth. In the U.S. increasing prevalence of chronic diseases and an aging population, are leading to increase in the number of surgical procedures performed every year. According to the U.S. Census Bureau, an estimated 75 million of the 328 million U.S. population, were aged 60 years and older in 2019. This implies that a significant number of American citizens are vulnerable to chronic and acute conditions, leading to an increased number of surgeries.

According to Definitive Healthcare, LLC, as of 2019, there were about 9,280 active ambulatory surgery centers in the U.S. This high number also contributes to market growth. In addition, ASCs enable large volumes of surgeries in a short period, which is expected to fuel the market growth during the forecast period.

The adoption of automated and robotic systems in surgery is another driver estimated to contribute to the market growth. In a study conducted by the University of Michigan, School of Medicine, it was found that from 2012 to 2018 the use of robotic technology in general surgery increased from 1.8% to 15.1%. Market players are leveraging this trend to introduce new products, expand their regional presence, and increase their market share. Bolder Surgical, partnered with Intuitive Surgical to provide an exclusive licensing agreement to its energy-based vessel sealing and tissue stapling technologies for use in the latter’s robotic-assisted surgery solutions. In May 2021, Bowa Medical opened a new office in Cairo to control and support sales activities for Turkey, Iran, Pakistan, and the entire Middle East region.

Request a free sample copy or view report summary: Vessel Sealing Devices Market Report

Vessel Sealing Devices Market Report Highlights

• Rising prevalence of chronic diseases is increasing the number of surgeries performed around the globe. This is one of the key contributing factors towards market growth
• The application segment was dominated by laparoscopic surgery in 2020 owing to wider use of vessel sealing devices in these procedures, while the general surgery segment held a significant share. In June 2021, for instance, Johnson and Johnson’s Ethicon launched ENSEAL X1 Curved Jaw Tissue Sealer for use in colorectal, bariatric surgery, gynecological, and thoracic procedures
• The laparoscopic surgery segment, however, is also anticipated to grow the fastest due to rise in technological advancements and minimally invasive surgeries
• The instruments segment held the largest revenue share in 2020 and is also expected to register the highest CAGR over the forecast period. Easy availability of instruments is one of the primary factors driving this segment
• The hospitals and specialty clinics segment held the largest revenue share of 57.4% in 2020, as they are the primary point of care for treatment. Furthermore, hospitals and specialty clinics are known to offer superior care to their patients and treatment at these centers are generally reimbursed, which drives adoption

Access Press Release@ https://www.grandviewresearch.com/press-release/global-vessel-sealing-devices-market

Vessel Sealing Devices Market Segmentation

Grand View Research has segmented the global vessel sealing devices market on the basis of application, product, end user, and region:

Vessel Sealing Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• General Surgery
• Laparoscopic Surgery

Vessel Sealing Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Generators
• Instruments
• Accessories

Vessel Sealing Devices End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers

Vessel Sealing Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Vessel Sealing Devices Market

• Medtronic
• Olympus Corporation
• Braun Melsungen AG
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• Erbe Elektromedizin GmbH
• Bowa Medical
• OmniGuide Holdings, Inc.
• Intuitive Surgical
• Bolder Surgical, LLC
• KLS Martin Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Australia Facial Injectables Market Soaring Demand Assures Motivated Revenue Share By 2028

 Australia Facial Injectables Market Growth & Trends

The Australia facial injectables market size is expected to reach USD 15.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 26.3% from 2021 to 2028. Augmented products such as botulinum toxin type A and Hyaluronic Acid (HA) fillers are used in combination to improve outcomes in the lower region of the face. HA fillers are mostly preferred by physicians due to lower hypersensitivity reactions, lower biodegradation, and higher viscosity; they also support the longevity of the restored volume after filler injection.

Body image is a major personal concern among the youth in the country. According to Mission Australia’s Youth Survey Report 2018, nearly 30.4% of participants were concerned about body image, with around 13.6% reporting to be extremely concerned, while approximately 16.8% of them were very concerned about their body image. The survey also revealed that women (~41.5%) were more concerned about body image as compared to men (~15.4%). Moreover, according to a 2017 study published in Psychiatry Research, nearly 3% of male teenagers in the country were reported to have symptoms of body dysmorphism. Thus, a large number of young people expressing concern about body image and physical appearance is anticipated to boost the demand for cosmetic procedures, thereby driving the market growth.

Social media as well as other traditional media and advertising platforms are also anticipated to have a significant impact on beauty standards and body image. For instance, the 2016 HuffPost Australia article stated that approximately 77% of women in Australia believed that media and advertising establish an unrealistic beauty standard, which is difficult to achieve. Persistent influence of media’s portrayal of a particular standard of beauty for young women is anticipated to trigger a desire for cosmetic procedures to achieve perceived beauty standards, thereby facilitating the market growth.

Request a free sample copy or view report summary: Australia Facial Injectables Market Report

Australia Facial Injectables Market Report Highlights

• The hyaluronic acidsegment emerged as the largest segment in 2020. This is attributed to increasing demand as a dermal filler or in cosmetic preparations due to strong water retention properties
• The botulinum toxin type A segment is anticipated to witness comparatively higher growth during the forecast period. This can be attributed to rise in applications of BoNTA in cosmetic (aesthetic) procedures
• The aesthetics segment dominated the market and accounted for the largest revenue share in 2020

Access Press Release@ https://www.grandviewresearch.com/press-release/australia-facial-injectables-market-analysis

Australia Facial Injectables Market Segmentation

Grand View Research has segmented the Australia facial injectables market based on product and application:

Australia Facial Injectables Product Outlook (Revenue, USD Million, 2016 - 2028)

• Collagen
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA) 
• Polymer Fillers
  • Polymethylmethacrylate Microspheres (PMMA)
  • PLLA (Poly-L-lactic acid)

Australia Facial Injectables Application Outlook (Revenue, USD Million, 2016 - 2028)

• Aesthetics
• Therapeutics

List of Key Players of Australia Facial Injectables Market

• SILK Laser Clinics
• Advanced Clinics Australia
• Results Laser Clinic
• Australian Skin Clinics
• Laser Clinics Australia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Middle East & Africa Aluminum Foil Packaging Market Booming Trends and Forecast Assessment for the Period 2021 to By 2028

 Middle East & Africa Aluminum Foil Packaging Market Growth & Trends

The Middle East & Africa aluminum foil packaging market size is expected to reach USD 2.85 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.8% over the forecast period. The growth is driven by the shift of oil economies in the Middle East toward non-oil industries, including food & beverage, pharmaceutical, and cosmetics.

Aluminum pouches and aluminum containers are being increasingly preferred for takeaway parcels by foodservice outlets owing to the performance benefits of aluminum foils. Aluminum foil packaging is recyclable and thereby expected to achieve significant gains in the flexible packaging segment in the region.

The governmental initiatives to curb the generation of plastic wastage are further expected to support market growth. In February 2017, officials in Jeddah, Saudi Arabia urged foodservice outlets, such as restaurants and bakeries, to stop using plastic bags and replace them with paper bags or aluminum foil containers. Such regulations are expected to be more prevalent in the coming years in response to the issues associated with plastic waste, thereby supporting the product demand.

Countries, such as Saudi Arabia and UAE, have witnessed an increased number of tourists over the past few years. This is expected to result in the growth of foodservice outlets and Quick-Service Restaurants (QSRs) in the region. This is expected to augment the consumption of aluminum packaging products, such as pouches and containers.

The COVID-19 pandemic has significantly increased the demand for home delivery of food packets due to restrictions on public movement on streets. Changing consumer behavior has resulted in increased demand at foodservice outlets, wherein aluminum packaging products are majorly used. This is expected to fuel the product demand for takeaway foods, thereby supporting market growth.

Request a free sample copy or view report summary: Middle East & Africa Aluminum Foil Packaging Market Report

Middle East & Africa Aluminum Foil Packaging Market Report Highlights

• In terms of revenue, the pouches segment is projected to ascend at the highest CAGR of 5.9% over the forecast period. Aluminum foil pouches are used as a primary packaging solution for products, such as tea or plant-based products, as it offers barrier properties against moisture, gases, and light and thereby retains the aroma of the packed products
• The pharmaceutical end-use segment accounted for a revenue share of 17.7% in 2020. With increasing governmental initiatives, such as the VISION 2030 plan of Saudi Arabia, towards the development of non-oil-based industries are expected to support pharmaceutical manufacturing in the region. This is expected to contribute to the market growth in the years to come
• Egypt is projected to be the fastest-growing region over the forecast period owing to the growing food & beverage and pharmaceutical industries. Pharmaceutical manufacturers in the country have been focusing on expanding production capacities to meet the growing demand for drugs. For instance, Sanofi increased the investment in pharmaceuticals in Egypt by 50% in 2019 to gain a higher market share
• Major manufacturers operating in Middle East & Africa (MEA) are increasingly emphasizing sustainable packaging solutions. For instance, in January and October 2018, Amcor plc and Constantia Flexibles pledged to make 100% of their portfolio recyclable or reusable by 2025, respectively. This is expected to support the production of aluminum foil-based packaging solutions

Access Press Release@ https://www.grandviewresearch.com/press-release/middle-east-africa-aluminum-foil-packaging-market-analysis

Middle East & Africa Aluminum Foil Packaging Market Segmentation

Grand View Research has segmented the Middle East & Africa aluminum foil packaging market on the basis of product, end use, and countries:

MEA Aluminum Foil Packaging Product Outlook(Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Foil Wraps
• Pouches
• Blisters
• Containers
• Others

MEA Aluminum Foil Packaging End-use Outlook(Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Food & Beverage
• Tobacco
• Pharmaceuticals
• Cosmetics
• Others

MEA Aluminum Foil Packaging Country Outlook(Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Saudi Arabia
• UAE
• South Africa
• Egypt
• Morocco
• Iran

List of Key Players of Middle East & Africa (MEA) Aluminum Foil Packaging Market

• Amcor plc
• Constantia Flexibles
• Novelis Aluminum
• Raviraj Foils Ltd.
• Ampco,
• Saudi Factory for Aluminum Foils and Containers
• Caterpack
• Alcon
• Technical Aluminium Foil Co. LLC
• Cosmoplast
• Symetal
• Aluminium Foil Converters
• UNIPACK
• Express Flexi Pack
• ERAMCO

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Germany Pet Insurance Market Insights Business Opportunities, Current Trends And Forecast 2028: Grand View Research Inc.

 Germany Pet Insurance Market Growth & Trends

The Germany pet insurance market size is anticipated to reach USD 1.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.1% from 2021 to 2028. The growth is attributable to the increasing prevalence of acute and chronic pet health diseases, the humanization of pets, and supportive government regulations. For example, liability insurance is compulsory for certain dangerous dog breeds in states including Saarland, Bremen, Hessen, Nordrhein-Westfalen, and Baden-Wurttemberg.

The COVID-19 outbreak catalyzed the market with a surge in pet adoption and pet health concerns. Wertgarantie Group, the parent company of Agila, reported an exponential rise in the purchase of dogs and cats in Germany in 2020, amid the COVID-19 pandemic. This positively affected the company’s pet health insurance business with about 340,000 new contracts. However, this number contrasted the 475,000 veterinary bills processed during the period for the benefit of customers. As pet owners are becoming increasingly concerned about their pet’s health and wellbeing, the demand for pet insurance is expected to increase over time due to the high costs of treatment and surgery, awareness about pet health and diseases, and the humanization of pets.

Market players are involved in providing affordable and tailored insurance products to suit the needs and budget of pet parents. These include monthly or annual plans, plans based on coverage type, and sold through various sales channels. Barmenia Insurance, for instance, offers horse surgery insurance that provides coverage, from colic protection to premium surgery costs. The company’s dog and cat health insurance plans come in 4 variants, wherein all plans cover operations, including partial anesthesia or local anesthesia with no annual maximum.

Service additions to enhance product value is another unique selling point observed in the market. DFV Deutsche Familienversicherung AG, for example, partnered with FirstVet to offer veterinary telemedicine services to its animal health policyholders, thus establishing itself as an Insurtech company.

Request a free sample copy or view report summary: Germany Pet Insurance Market Report

Germany Pet Insurance Market Report Highlights

• The dogs’ segment held the largest revenue share of 57.5% in 2020
• The factors contributing to market growth include an increase in the number of pets, pet care expenditure, and chronic conditions such as joint disorders, fractures, and trauma, which require expensive treatments or surgical interventions
• The health insurance segment dominated the market and accounted for a revenue share of 80.0% in 2020, owing to growing pet health concerns, and the need to curb expenditure
• The agency segment dominated the market and accounted for a revenue share of over 56.0% in 2020
• The broker segment, on the other hand, is expected to register notable growth in the coming years. SantéVet for instance provides a range of pet insurance products, wherein guarantees are taken out through an insurance brokerage company, Vetassur. SantéVet also partners with other brokers to reach more customers and gain market share

Access Press Release@ https://www.grandviewresearch.com/press-release/germany-pet-insurance-market-analysis

Germany Pet Insurance Market Segmentation

Grand View Research has segmented the Germany pet insurance market on the basis of coverage type, animal type, and sales channel:

Germany Pet Insurance Coverage Type Outlook (Revenue, USD Million, 2016 - 2028)

• Liability Insurance
• Health Insurance
  • Accident Only
  • Lifetime
  • Surgery

Germany Pet Insurance Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Dogs
• Cats
• Horses

Germany Pet Insurance Sales Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Agency
• Broker
• Bancassurance
• Direct Writing

List of Key Players of Germany Pet Insurance Market

• Petplan
• Barmenia Versicherungen aG
• ELEMENT Insurance AG
• Coya Ltd.
• DFV Deutsche Familienversicherung AG
• Getsafe GmbH
• Helvetia Insurance
• AGILA Pet Insurance AG
• SantéVet
• Balunos

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Insufflation Devices Market to Reach Around USD 3.76 Billion by 2028: Grand View Research Inc.

 Insufflation Devices Market Growth & Trends

The global insufflation devices market size is expected to reach USD 3.76 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.3% from 2021 to 2028. Increasing adoption of minimally invasive surgeries, rapidly aging population, and rising number of laparoscopic procedures are among the major factors driving this market’s growth.

The COVID-19 outbreakhas caused the global implementation of strict measures to curbthe spread, which has led to the cancelation/delayof elective surgeries, including many laparoscopic procedures world wide. A large number of medical device manufacturing companies and global suppliers have been adversely affected during this time. However, with the abundance of deferred medical procedures in the pipeline, the market is likely to rebound and grow significantly over the forecast period.

Obesity or overweight are major health concerns that lead to a number of associated diseases or complications, such as diabetes and cardiovascular diseases. As per the WHO, in 2016, over 1.9 billion adults were overweight, out of which around 650 million people were obese and around 2.8 million people die each year as a result of being overweight/obese. Such instances are expected to increase the demand for bariatric procedures and other related surgeries, thereby propelling the market growth over the forecast period.

Moreover, growing patient preference for minimally invasive surgeries owing to the reduced risk and trauma associated with these procedures is expected to strengthen the growth of this market. Additionally, minimally invasive laparoscopic surgeries are increasingly being covered by health insurance providers in selected countries. For instance, for laparoscopic surgical operations, Medicare will cover up to 75% of the fee as listed in the Medicare Benefits Schedule. These factors have led to an increased preference for minimally invasive surgeries among patients.

Request a free sample copy or view report summary: Insufflation Devices Market Report

Insufflation Devices Market Report Highlights

• Based on application, the laparoscopic surgery segment dominated the market with a share of more than 35.0% in 2020
• On the basis of end use, the hospitals segment dominated the market with a share of more than 60.0% in 2020
• North America dominated the market with a revenue share of over 35.0% in 2020 owing to the increasing number of laparoscopic procedures and technological advancements
• In Asia Pacific, the market is anticipated to witness remarkable growth over the forecast period due to the presence of a large patient base suffering from chronic disorders and government initiatives for minimizing risks during the treatment

Access Press Release@ https://www.grandviewresearch.com/press-release/global-insufflation-devices-market

Insufflation Devices Market Segmentation

Grand View Research has segmented the global insufflation devices market on the basis of application, end use, and region:

Insufflation Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Laparoscopic Surgery
• Bariatric Surgery
• Cardiac Surgery
• Others

Insufflation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Insufflation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Insufflation Devices Market

• Fujifilm
• Medtronic
• Stryker
• BD
• Olympus
• Braun Melsungen
• Smith & Nephew
• Karl Storz
• Steris
• CONMED
• Richard Wolf

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pouches Market Key Players ,Industry Share ,Growth, And Forecast To 2028: Grand View Research Inc.

 Pouches Market Growth & Trends

The global pouches market size is expected to reach USD 55.88 billion by 2028, expanding at a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Rising demand for low-cost, convenient, shelf appealing, and lightweight packaging by end-use industries, including food and beverages, healthcare, personal care and cosmetics, and home care, is likely to fuel market growth.

Pouches demand lesser material, energy, and water during their manufacturing and thus prove to be significantly less expensive than rigid packaging solutions. In addition, lightweight and flexibility attribute for their lower transportation cost, due to which Consumer Products (CPG) companies are increasingly opting for pouches over rigid tubes, containers, and boxes.

Flat pouches occupy lesser space in retail outlets and can be easily stacked upon each other; thus, more products can be displayed as compared to other packaging types. Furthermore, standup pouches on retail shelves prove to be more appealing to the consumers, and the packaging format also has a higher surface area on which high-quality graphics are printed, owing to which the product type easily grabs customer attention in retail outlets as compared to bottles and boxes.

Various closures such as a zipper, spout, and tear notch are utilized in pouches, which provide convenience in pouch opening and closing. In addition, the product is usually made up of plastic composite films, paper, and aluminum laminates that provide a strong barrier against moisture, light, odor, and bacteria due to which food and beverages are increasingly offered in the packaging.

The increasing demand for packaged food and beverage products and growing on the go food consumption trend owing to the changing lifestyle is expected to augment growth to the market in the forecast period.

In addition, due to features including portability and lower product weight, pouches are the preferred packaging format for baby food products. The increasing working women population across the world is principally driving the demand for packaged baby food, which in turn is expected to benefit the market over the forecast period.

Request a free sample copy or view report summary: Pouches Market Report

Pouches Market Report Highlights

• The food and beverage end-use segment accounted for a share of 55.3% in terms of revenue in 2019, owing to its wide scale incorporation of the product for the packaging of dairy, snacks, sauces, confectionery, beverages, and other food products
• The aseptic treatment type segment is anticipated to witness a CAGR of 6.4% from 2020 to 2027 and is projected to reach USD 10.6 billion in 2027. Aseptic treatment type ensures that the product is free from bacteria and eliminates the need for refrigeration and thus proves to be cost-efficient
• The stand-up type segment is expected to witness the highest CAGR of 6.3% from 2020 to 2027. Growing adoption of stand-up product type due to their marketing advantages and convenience of use are attributing to the growth of the segment
• In Asia Pacific, the market is estimated to witness a CAGR of 6.5% from 2020 to 2027 on account of rapid growing packaged food industry and rising penetration of organized retail
• The market is highly fragmented with the presence of a large number of domestic as well as global players. key players are adopting merger and acquisition strategies to expand their manufacturing capabilities and geographical footprints.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pouches-market

Pouches Market Segmentation

Grand View Research has segmented the global pouches market on the basis of material, treatment type, product, end-use, closure type, and region:

Pouches Material Outlook (Revenue, USD Million, 2017 - 2028)

• Plastic
• Metal
• Paper
• Bioplastics

Pouches Treatment Type Outlook (Revenue, USD Million, 2017 - 2028)

• Standard
• Aseptic
• Retort
• Hot-fill

Pouches Product Outlook (Revenue, USD Million, 2017 - 2028)

• Flat
• Stand-up

Pouches End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Food & Beverages
• Healthcare
• Personal Care & Cosmetics
• Homecare
• Others

Pouches Closure Type Outlook (Revenue, USD Million, 2017 - 2028)

• Tear Notch
• Zipper
• Spout

Pouches Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Pouches Market

• Amcor plc
• Mondi
• Sealed Air
• CONSTANTIA
• Coveris
• Goglio SpA
• ProAmpac
• GUALAPACK S.P.A
• Huhtamaki Group
• Smurfit Kappa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Skilled Nursing Facility And Rehabilitation Market Is Expected To Accomplish A Valuation Of Around USD 281.6 Billion By 2028: Grand View Research Inc.

 U.S. Skilled Nursing Facility And Rehabilitation Market Growth & Trends

The U.S. skilled nursing facility and rehabilitation market size is expected to reach USD 281.6 billion by 2028, expanding at a CAGR of 3.4%, according to a new report by Grand View Research, Inc. The growing incidences of chronic conditions such as diabetes, paralysis, and hypertension and the rising geriatric population are factors expected to fuel the market over the next few years. In 2019, the geriatric population over 65 has increased up to 9.0% out of which 14.3 majorities of adults above the age of 65 years suffered from chronic disease and need these facilities. Medicare and Medicaid availability and the growing technologies will play a driving role for the market in the coming years.

To cope with the COVID-19 situation, in November 2020, the Centers for Medicare and Medicaid Services released guidelines for skilled nursing facilities to help curb the spread of the novel COVID-19 infection. These measures include physical distancing (maintain a distance of 6 feet from people), wearing a face mask, and limiting the number of visitors (keeping it one at a time). Majority of these facilities were not allowed to accept new residents and did not have new revenue streams for the additional expenses associated with the virus, which had a negative impact on the sector.

Request a free sample copy or view report summary: U.S. Skilled Nursing Facility And Rehabilitation Market Report

U.S. Skilled Nursing Facility And Rehabilitation Market Report Highlights

• The freestanding segment dominated the market in 2020 due to its lower cost compared to the hospital-based facility. The segment is expected to continue its dominance and witness a significant growth rate over the forecast period
• Skilled nursing facilities are reimbursed by medicare part A and B resulting in more sustainability, thereby propelling the growth of the market
• The market includes small and large players, leading to higher competition among smaller players to sustain their market position. The market is quite open for new entrants due to government support and great reimbursement policies
• Mergers and acquisitions are key strategic initiatives undertaken by market players to sustain in the competitive market. For instance, in December 2020, The Ensign Group, Inc. acquired Hays Nursing and Rehabilitation Center, a 116-bed skilled nursing facility located in Texas
• To provide skilled nursing and rehabilitation service during the COVID-19 pandemic, many skilled nursing and rehabilitation facilities came up with remote programs to serve the patients remotely. For instance, Mount Sinai Health System is using MindMaze’s MindMotionGO platform, to track body movements of patients using optical motion-capture technology. It enables the therapist to monitor the motor recovery process. With the help of such technological solutions, the continuation of rehabilitation services during the pandemic is possible, while reducing the burden on hospitals and other facilities

Access Press Release@ https://www.grandviewresearch.com/press-release/us-skilled-nursing-facility-rehabilitation-market-analysis

U.S. Skilled Nursing Facility And Rehabilitation Market Segmentation

Grand View Research has segmented the U.S. skilled nursing facility and rehabilitation market on the basis of type of facility:

U.S. Skilled Nursing Facility And Rehabilitation Type of Facility Outlook (Revenue, USD Billion, 2016 - 2028)

• Freestanding
• Hospital

List of Key Players of U.S. Skilled Nursing Facility And Rehabilitation Market

• Brookdale Senior Living, Inc
• The Ensign Group, Inc
• Genesis Healthcare, Inc
• Extendicare
• Sunrise Senior Living, LLC
• ProMedica
• Golden Living Centers
• Life Care Centers of Amer

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Orthopedic Regenerative Surgical Products Market Expected to Collect USD 5.2 Billion by the End of 2028: Grand View Research Inc.

 Orthopedic Regenerative Surgical Products Market Growth & Trends

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 3.6% from 2021 to 2028. The key factors driving the market growth include the rising geriatric population, orthopedic procedures, research activities, and technological advancements. Osteoarthritis, for instance, has been identified as the leading cause of chronic disability in the geriatric population over the age of 70. The World Health Organization (WHO) has also designated osteoarthritis as a ‘priority disease’ promoting R&D for therapies to treat osteoarthritis and its associated symptoms.

The growth of the market was restrained during the COVID-19 pandemic due to deferred elective surgeries, low volume of patient flow for chronic conditions in clinics and hospitals, decreased sales and marketing activities, quarantine and lockdown protocols, and low demand. Vericel Corporation, for example, reported the adverse impact of COVID-19 on its business and operations during 2020. The company registered cancellations of scheduled MACI procedures; its key product used in the repair of cartilage damage of the knee. In addition, there was a slowdown in new orders. Anika Therapeutics reported challenges in patient enrollment for its clinical trials due to the pandemic, which negatively impacted on the company’s revenue and operating results. However, both companies expect recovery financial performance as elective surgeries resume to pre-COVID numbers.

According to the Centers for Disease Control and Prevention (CDC), about 26% (or 78 million) the U.S. adults are estimated to suffer from arthritis by 2040. The prevalence increases with age and is found to be more common in women. Obesity has been identified as another risk factor contributing to orthopedic conditions. The prevalence of obesity in the U.S. was estimated at 42.4% from 2017 to 2018 by the CDC. The increasing prevalence of orthopedic diseases, obesity, and geriatric population is expected to fuel the market growth. Orthopedic regenerative surgical products find application in different conditions of varying severity from joint pain, gout, articular defects, fibromyalgia, and osteoarthritis, to trauma and joint replacement, this is expected to contribute to the market growth.

Market players are also involved in research and development activities to launch new regenerative solutions for treatment or pain relief from orthopedic conditions. Amniox Medical, Inc. for instance, received FDA clearance to proceed with a dosing study using TTAX03- its Investigational New Drug (IND) comprising cryopreserved amniotic membrane and umbilical cord, to treat facet joint osteoarthritis pain in March 2021. Zimmer Biomet on the other hand, offers an extensive portfolio of allografts and synthetic orthopedic regenerative products such as the PrimaGen Advanced allograft, InterGro DBM, and PlatFORM bioresorbable bone graft substitute.

Request a free sample copy or view report summary: Orthopedic Regenerative Surgical Products Market Report

Orthopedic Regenerative Surgical Products Market Report Highlights

• Key factors driving the market include an aging population across the globe and a rise in the prevalence of orthopedic diseases. According to a 2019 review article published in the Elderly Health Journal, the prevalence of knee osteoarthritis in various Asian countries was found to be in a range of 13.1 - 71.1%
• The viscosupplements segment dominated the market and accounted for the largest revenue share of 42.7% in 2020 owing to the increasing prevalence of osteoarthritis and related symptoms and product availability
• Monovisc and Orthovisc by Anika Therapeutics are the leading products in the viscosupplement market in the U.S. since 2018, based on combined overall revenue
• In terms of application, the cartilage and tendon repair segment is estimated to witness the fastest CAGR of 3.8% followed by trauma repair and orthopedic pain management
• According to a 2019 study on Cartilage Restoration Surgerypublished by the National Library of Medicine, complications in cartilage restoration procedures have been rising for the past 2 decades. The results also indicated a paradigm shift toward osteochondral grafting procedures and other more complex cartilage procedures
• As most orthopedic procedures are performed within hospital settings, the hospitals segment held the largest revenue share of 50.4% in 2020
• Drivers include a large number of populations affected by joint pain and other debilitating orthopedic conditions and supportive initiatives by governments and regulatory bodies. For example, 12 October was established as the World Arthritis Day by the Arthritis and Rheumatism International (ARI)to raise awareness about rheumatic and musculoskeletal diseases

Access Press Release@ https://www.grandviewresearch.com/press-release/global-orthopedic-regenerative-surgical-products-market

Orthopedic Regenerative Surgical Products Market Segmentation

Grand View Research has segmented the orthopedic regenerative surgical products market on the basis of product, application, end user, and region:

Orthopedic Regenerative Surgical Products Outlook (Revenue, USD Million, 2016 - 2028)

• Allograft
  • Amniotic Products
  • Others
• Synthetic
• Cell-based
• Viscosupplements

Orthopedic Regenerative Surgical Products Application Outlook (Revenue, USD Million, 2016 - 2028)

• Orthopedic Pain Management
• Trauma Repair
• Cartilage and Tendon Repair
• Joint Reconstruction
• Others

Orthopedic Regenerative Surgical Products End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers
• Others (Orthopedic Specialty Centers, Clinics)

Orthopedic Regenerative Surgical Products Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Orthopedic Regenerative Surgical Products Market

• Anika Therapeutics, Inc.
• Vericel Corporation
• Baxter
• Zimmer Biomet
• Stryker
• Smith+Nephew
• AlloSource
• Amniox Medical, Inc.
• VSY Biotechnology
• Aptissen S.A
• MiMedx

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Attractive Market Opportunities in the Indiana Homecare Enteral Feeding Formula Market by 2028: Grand View Research Inc.

 Indiana Homecare Enteral Feeding Formula Market Growth & Trends

The Indiana homecare enteral feeding formula market size is expected to reach USD 127.9 million by 2028 and is expected to expand at a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. The rapidly growing global geriatric population is susceptible to chronic medical ailments such as diabetes, neurological disorders, cardiovascular diseases, stroke, and end-stage cardiac failure, which require clinical dietary management. As per the Indiana State Health Plan, the leading causes of death are CVD, diabetes, stroke, and cancer. According to Administration for Community Living in 2016, there were 49.2 million U.S citizens above the age of 65 years and, is expected to reach 82.3 million by 2040. It experienced an increase of 33% from 2006 to 2016. The rapidly aging society and pursual of an unhealthy lifestyle enhance the disease burden imposed by the geriatric population. The growing geriatric population, rising prevalence of chronic diseases, and product innovation in the homecare therapies segment are boosting market growth.

The growing rate of globalization, increasing pursual of unhealthy lifestyle habits, minimal physical activity, increased consumption of junk food and beverages, and tobacco and alcohol consumption if leading to the high global prevalence of chronic ailments and targeted diseases. Market players are constantly focusing on drug discovery and development to curate disease-specific formulas. Clinical nutrition is increasingly being used to personalize the treatment of chronic diseases such as cancer and cystic fibrosis. For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of this digestive enzyme could vary in individuals. Established market players such as Nestle provide personalized clinical nutrition formulations such as Deplin for depression and Metanx for diabetes. As per studies, 70% of patients suffering from depression have a low ability to activate folate, and thus the need for specialized formulations, such as Deplin, is rising. Additionally, research activities in nutrigenomics, proteomics, and metabolomics to establish links between food and genes are rising and provides the impetus to the clinical nutrition market in personalized treatment regimens.

The development of gastrointestinal disorders, such as GI hypomotility in Covid-19 positive patients, contributed to the rise in demand for enteral feeding formulations. As per several studies, the use of enteral feed formulations for patients suffering from malnutrition due to contracting Covid-19 is justified. For instance, as per an article published in the Journal of the Academy of Nutrition and Dietetics, several patients admitted to the ICU for Covid-19 treatment suffer from acute malnourishment. Therefore, the use of clinical nutrition formulations is expected to increase in hospital and home care settings during the Covid-19 pandemic.

Request a free sample copy or view report summary: Indiana Homecare Enteral Feeding Formula Market Report

Indiana Homecare Enteral Feeding Formula Market Report Highlights

• The standard formula product segment dominated the market in 2020 due to the high usage of enteral nutrition for basic clinical nutritional needs and easy commercial availability
• The intermittent feeding flow type segment dominated the market in 2020 due to the growing prevalence of neuromuscular disorders and allows greater patient mobility and physiological efficiency
• The adults' segment dominated the market in 2020 owing to the increasing prevalence of malnourishment, impaired immunity, and poor muscle strength
• The others indication segment dominated the market in 2020 owing to the growing prevalence of other chronic diseases such as COPD, cystic fibrosis, and other respiratory ailments

Access Press Release@ https://www.grandviewresearch.com/press-release/indiana-homecare-enteral-feeding-formula-market-analysis

Indiana Homecare Enteral Feeding Formula Market Segmentation

Grand View Research, Inc. has segmented the Indiana homecare enteral feeding formula market report on the basis of product, flow type, stage, and indication:

Indiana Homecare Enteral Feeding Formula Product Outlook (Revenue, USD Million, 2016 - 2028)

• Standard Formula
• Disease-specific Formula

Indiana Homecare Enteral Feeding Formula Flow Type Outlook (Revenue, USD Million, 2016 - 2028)

• Intermittent Feeding Flow
• Continuous Feeding Flow

Indiana Homecare Enteral Feeding Formula Stage Outlook (Revenue, USD Million, 2016 - 2028)

• Pediatrics
• Adults

Indiana Homecare Enteral Feeding Formula Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Alzheimer’s
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Disease
• Orphan Disease
• Dysphagia
• Pain Management
• Malabsorption/ GI Disorder/ Diarrhea
• Others

List of Key Players of Indiana Homecare Enteral Feeding Formula Market

• Mead Johnson & Company, LLC
• Byram Healthcare Centers, Inc.
• Real Food Blends
• Kate Farms
• Nutritional Medicinals, LLC
• Shield Healthcare, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thailand Aesthetic Medicine Market Industry Analysis , Opportunity Assessment And Forecast Till 2028: Grand View Research Inc.

 Thailand Aesthetic Medicine Market Growth & Trends

The Thailand aesthetic medicine market size is expected to reach USD 1.89 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.6% from 2021 to 2028. The market is majorly driven by the increasing adoption of minimally invasive and non-invasive procedures, coupled with the growth in the population susceptible to signs of aging. Moreover, an increase in the incidence of road accidents is driving the demand for reconstructive surgeries, which is fuelling the growth of the aesthetic medicine market in the country.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), among Asian countries, Thailand is among the top ten countries with the highest number of invasive as well as non-invasive procedures. Cities such as Bangkok and Phuket are major cosmetic surgery hubs in the country, which have clusters of major aesthetic surgery hospitals and clinics.

According to a survey by the International Society of Aesthetic Plastic Surgery in 2019, around 92,597 invasive aesthetic procedures were performed in the country. Moreover, Thailand is a tourism-dependent economy where medical tourism is flourishing due to low treatment costs and high-quality post-treatment services. According to the Journal of Community Development Research, Thailand’s medical tourism industry expanded with a 10% revenue growth in 2019 from 2018. These factors might boost the growth of the aesthetic medicine market.

The advent of the Covid-19 pandemic has resulted in the cessation of medical tourism in Thailand. The majority of the medical tourists visit the country for cosmetic procedures, however, the international travel ban and lockdown restrictions due to the pandemic have resulted in the shutting down of aesthetic clinics, thereby affecting the country’s aesthetic medicine market. However, according to Bangkok Post, Thailand Centre for Covid-19 Situation Administration stated that they have resumed the country’s medical and wellness tourism program intending to attract medical tourists back into the country. The aesthetic market revenue is expected to plunge back to pre-Covid levels by the end of 2022.

Request a free sample copy or view report summary: Thailand Aesthetic Medicine Market Report

Thailand Aesthetic Medicine Market Report Highlights

• Based on procedure type, the invasive procedures segment accounted for the largest share of 74.6% in 2020. This is because the country sees a majority of medical tourists for aesthetic surgical procedures
• In the invasive procedures segment, eyelid surgery is expected to register the highest CAGR of 14.4% over the forecast period. As a majority of the Thai population does have sagging eyelids, people opt for eyelid surgeries to gain a defined eye shape and remove sagging
• The non-invasive procedures segment is expected to witness the highest growth over the forecast period due to its minimally invasive characteristics, immediate results, and low recovery period
• In the non-invasive procedures segment, Botox injections held the largest market share in 2020 and are expected to exhibit a significant CAGR over the forecast period. This is mainly due to the availability of wide applications of Botox injections
• On the basis of end use, clinics and aesthetic centers held the largest share of 69.3% in 2020. This is due to the fact that aesthetic clinics are increasingly offering customized treatments at cost-effective prices

Access Press Release@ https://www.grandviewresearch.com/press-release/thailand-aesthetic-medicine-market-analysis

Thailand Aesthetic Medicine Market Segmentation

Grand View Research has segmented the Thailand aesthetic medicine market on the basis of procedure type and end-use:

Thailand Aesthetic Medicine Procedure Type Outlook (Revenue, USD Million, 2016 - 2028)

• Invasive Procedures
  • Breast Augmentation
  • Liposuction
  • Nose Reshaping
  • Eyelid Surgery
  • Tummy Tuck
  • Others
• Non-invasive Procedures
  • Botox Injections
  • Soft Tissue Fillers
  • Chemical Peel
  • Laser Hair Removal
  • Microdermabrasion
  • Others
    • Skin Tightening (Thermage/Ulthera)
    • Non-invasive Fat Reduction/Body Contouring
    • Others

Thailand Aesthetic Medicine End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics & Aesthetic Centres

List of Key Players of Thailand Aesthetic Medicine Market

• Dermaster Co., Ltd.
• BSL Clinic
• Thai Medical Vacation
• Bumrungrad International Hospital
• Orawan Holistic Dermatology & Anti-Aging Institute
• Nirunda International Aesthetic Clinic

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.